Pharma Stocks
-
Should Merck’s (MRK) New STK-012 Keytruda Lung Cancer Combo Strategy Require Action From Investors?
In late February 2026, Synthekine announced a collaboration and supply agreement with Merck to test STK-012 alongside Keytruda and chemotherapy…
Read More » -
Amphastar Pharmaceuticals (AMPH) Margin Compression Reinforces Bearish Narratives Despite Low 9.5x P/E
Amphastar Pharmaceuticals (AMPH) closed out FY 2025 with Q4 revenue of US$183.1 million and basic EPS of US$0.53, alongside net…
Read More » -
Indivior’s Strong 2025 Results and US$400 Million Buyback Might Change The Case For Investing In Indivior Pharmaceuticals (INDV)
In February 2026, Indivior Pharmaceuticals, Inc. reported fourth-quarter 2025 sales of US$358 million and net income of US$102 million, alongside…
Read More » -
Terns Pharmaceuticals (TERN) Valuation Check After Strong Recent Share Price Run And CML Narrative Shift
Terns Pharmaceuticals (TERN) has drawn attention after recent trading, with the stock closing at US$40.92. For investors, the clinical stage…
Read More » -
Needham Lifts PT on Ionis Pharmaceuticals (IONS) to $103 From $90
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) is one of the best strong buy healthcare stocks to invest in. Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)…
Read More » -
Amphastar Pharmaceuticals (AMPH) Q4 Earnings and Revenues Lag Estimates
Amphastar Pharmaceuticals (AMPH) came out with quarterly earnings of $0.73 per share, missing the Zacks Consensus Estimate of $0.97 per…
Read More » -
Catalyst Pharmaceuticals Q4 Earnings Beat, Firdapse Revenues Rise Y/Y
Catalyst Pharmaceuticals CPRX reported adjusted earnings of 68 cents per share for the fourth quarter of 2025, beating the Zacks Consensus…
Read More » -
4597.T stock: Solasia Pharma JPX +10% to JPY 33.00 on 54.51M volume: catalysts 26 Feb 2026
Solasia Pharma K.K. (4597.T) closed higher on 26 Feb 2026, rising 10.00% to JPY 33.00 on heavy volume of 54,508,500.00…
Read More » -
Mankind Pharma Sees Sharp Open Interest Surge Amid Strong…
Open Interest and Volume Dynamics The latest data reveals that Mankind Pharma’s open interest in futures and options contracts rose…
Read More » -
Jazz Pharmaceuticals (JAZZ) Stock Trades Up, Here Is Why
What Happened? Shares of biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) jumped 13.5% in the afternoon session after the company reported better-than-expected…
Read More »